Patent: 10,493,054
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,493,054
| Title: | Docetaxel albumin nanoparticle pharmaceutical composition, preparation method therefor and use thereof |
| Abstract: | The present invention relates to a docetaxel albumin nanoparticle pharmaceutical composition, a preparation method therefor, and a use thereof for manufacturing drugs for treating cancer. The pharmaceutical composition comprises docetaxel, albumin and amino acid(s), wherein the weight ratio between albumin and docetaxel is no more than 50, preferably is 20:1 to 1:1, and the weight ratio between amino acid(s) and docetaxel is not less than 0.5, preferably is 1:1 to 20:1. |
| Inventor(s): | Su; Zhengxing (Sichuan, CN), Yang; Likai (Sichuan, CN), Zhao; Dong (Sichuan, CN), Zhou; Jing (Sichuan, CN), Shan; Fengying (Sichuan, CN), Wang; Lichun (Sichuan, CN), Wang; Jingyi (Sichuan, CN) |
| Assignee: | SICHUAN KELUN PHARMACEUTICAL RESEARCH INSTITUTE CO. LTD. (Chengdu, Sichuan, CN) |
| Application Number: | 15/548,443 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,493,054
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2035-04-03 |
| Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2035-04-03 |
| Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2035-04-03 |
| Grifols Biologicals Llc | ALBUTEIN | albumin (human) | Injection | 102478 | 08/15/1978 | ⤷ Try a Trial | 2035-04-03 |
| Instituto Grifols, S.a. | HUMAN ALBUMIN GRIFOLS | albumin (human) | Injection | 103352 | 02/17/1995 | ⤷ Try a Trial | 2035-04-03 |
| Instituto Grifols, S.a. | HUMAN ALBUMIN GRIFOLS | albumin (human) | Injection | 103352 | 06/11/2003 | ⤷ Try a Trial | 2035-04-03 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
